Counterpoint Quantitative Equity ETF $CPAI is Counterpoint Mutual Funds LLC’s 5th Largest Position

Counterpoint Mutual Funds LLC lifted its position in Counterpoint Quantitative Equity ETF (NYSEARCA:CPAI) by 5.0% during the 3rd quarter, HoldingsChannel reports. The firm owned 1,300,416 shares of the company’s stock after buying an additional 61,500 shares during the period. Counterpoint Quantitative Equity ETF comprises about 4.1% of Counterpoint Mutual Funds LLC’s investment portfolio, making the stock its 5th biggest position. Counterpoint Mutual Funds LLC owned approximately 0.41% of Counterpoint Quantitative Equity ETF worth $51,357,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the business. JPMorgan Chase & Co. grew its position in Counterpoint Quantitative Equity ETF by 5.4% during the third quarter. JPMorgan Chase & Co. now owns 6,461 shares of the company’s stock worth $255,000 after buying an additional 331 shares in the last quarter. Global Assets Advisory LLC purchased a new stake in shares of Counterpoint Quantitative Equity ETF in the 3rd quarter valued at about $1,109,000. Inscription Capital LLC boosted its position in shares of Counterpoint Quantitative Equity ETF by 5.1% during the 3rd quarter. Inscription Capital LLC now owns 31,650 shares of the company’s stock valued at $1,250,000 after acquiring an additional 1,550 shares during the last quarter. Concurrent Investment Advisors LLC grew its holdings in shares of Counterpoint Quantitative Equity ETF by 59.4% during the third quarter. Concurrent Investment Advisors LLC now owns 72,844 shares of the company’s stock worth $2,877,000 after purchasing an additional 27,135 shares in the last quarter. Finally, U.S. Capital Wealth Advisors LLC increased its position in shares of Counterpoint Quantitative Equity ETF by 49.3% in the third quarter. U.S. Capital Wealth Advisors LLC now owns 93,556 shares of the company’s stock worth $3,695,000 after purchasing an additional 30,896 shares during the last quarter.

Counterpoint Quantitative Equity ETF Price Performance

Shares of CPAI opened at $43.37 on Tuesday. Counterpoint Quantitative Equity ETF has a 1-year low of $28.48 and a 1-year high of $45.09. The company has a market capitalization of $175.21 million, a P/E ratio of -52,002.40 and a beta of 1.25. The firm’s 50 day simple moving average is $42.56 and its 200 day simple moving average is $40.06.

Counterpoint Quantitative Equity ETF Announces Dividend

The business also recently announced an annual dividend, which was paid on Wednesday, December 17th. Investors of record on Friday, December 12th were given a $0.3577 dividend. The ex-dividend date was Friday, December 12th. This represents a yield of 89.0%. Counterpoint Quantitative Equity ETF’s payout ratio is -16,786.57%.

Counterpoint Quantitative Equity ETF Company Profile

The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.